These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 30466089

  • 1. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
    Wang X, Liu Y, Xiao L, Li L, Zhao X, Yang L, Chen N, Gao L, Zhang J.
    Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089
    [Abstract] [Full Text] [Related]

  • 2. Tamarixetin protects against cardiac hypertrophy via inhibiting NFAT and AKT pathway.
    Fan C, Li Y, Yang H, Cui Y, Wang H, Zhou H, Zhang J, Du B, Zhai Q, Wu D, Chen X, Guo H.
    J Mol Histol; 2019 Aug; 50(4):343-354. PubMed ID: 31111288
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Exploring the role and mechanism of hyperoside against cardiomyocyte injury in mice with myocardial infarction based on JAK2/STAT3 signaling pathway.
    Rao T, Tong H, Li J, Huang J, Yin Y, Zhang J.
    Phytomedicine; 2024 Jun; 128():155319. PubMed ID: 38518637
    [Abstract] [Full Text] [Related]

  • 6. The role and mechanism of hyperoside against myocardial infarction in mice by regulating autophagy via NLRP1 inflammation pathway.
    Yang Y, Li J, Rao T, Fang Z, Zhang J.
    J Ethnopharmacol; 2021 Aug 10; 276():114187. PubMed ID: 33957207
    [Abstract] [Full Text] [Related]

  • 7. Carnosol prevents cardiac remodeling and ventricular arrhythmias in pressure overload-induced heart failure mice.
    Fang Z, Lu M, Huang R, Wang G, Yushanjiang F, Jiang X, Li J.
    Phytother Res; 2024 Jul 10; 38(7):3763-3781. PubMed ID: 38831669
    [Abstract] [Full Text] [Related]

  • 8. Melatonin protects against the pathological cardiac hypertrophy induced by transverse aortic constriction through activating PGC-1β: In vivo and in vitro studies.
    Zhai M, Liu Z, Zhang B, Jing L, Li B, Li K, Chen X, Zhang M, Yu B, Ren K, Yang Y, Yi W, Yang J, Liu J, Yi D, Liang H, Jin Z, Reiter RJ, Duan W, Yu S.
    J Pineal Res; 2017 Oct 10; 63(3):. PubMed ID: 28708271
    [Abstract] [Full Text] [Related]

  • 9. Bakuchiol protects against pathological cardiac hypertrophy by blocking NF-κB signaling pathway.
    Wang Z, Gao L, Xiao L, Kong L, Shi H, Tian X, Zhao L.
    Biosci Rep; 2018 Oct 31; 38(5):. PubMed ID: 30242058
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Oleanolic acid alleviated pressure overload-induced cardiac remodeling.
    Liao HH, Zhang N, Feng H, Zhang N, Ma ZG, Yang Z, Yuan Y, Bian ZY, Tang QZ.
    Mol Cell Biochem; 2015 Nov 31; 409(1-2):145-54. PubMed ID: 26215454
    [Abstract] [Full Text] [Related]

  • 12. Oridonin protects against cardiac hypertrophy by promoting P21-related autophagy.
    Xu M, Wan CX, Huang SH, Wang HB, Fan D, Wu HM, Wu QQ, Ma ZG, Deng W, Tang QZ.
    Cell Death Dis; 2019 May 24; 10(6):403. PubMed ID: 31127082
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
    Lin H, Li Y, Zhu H, Wang Q, Chen Z, Chen L, Zhu Y, Zheng C, Wang Y, Liao W, Bin J, Kitakaze M, Liao Y.
    Cardiovasc Res; 2020 Jan 01; 116(1):101-113. PubMed ID: 30689763
    [Abstract] [Full Text] [Related]

  • 15. Nuclear Localization Leucine-Rich-Repeat Protein 1 Deficiency Protects Against Cardiac Hypertrophy by Pressure Overload.
    Zong J, Li FF, Liang K, Dai R, Zhang H, Yan L, Liu JL, Xu LH, Qian WH.
    Cell Physiol Biochem; 2018 Jan 01; 48(1):75-86. PubMed ID: 30001530
    [Abstract] [Full Text] [Related]

  • 16. LCZ696 Ameliorates Oxidative Stress and Pressure Overload-Induced Pathological Cardiac Remodeling by Regulating the Sirt3/MnSOD Pathway.
    Peng S, Lu XF, Qi YD, Li J, Xu J, Yuan TY, Wu XY, Ding Y, Li WH, Zhou GQ, Wei Y, Li J, Chen SW, Liu SW.
    Oxid Med Cell Longev; 2020 Jan 01; 2020():9815039. PubMed ID: 33014281
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
    Zhu W, Wu RD, Lv YG, Liu YM, Huang H, Xu JQ.
    Biomed Pharmacother; 2020 Jan 01; 121():109368. PubMed ID: 31707348
    [Abstract] [Full Text] [Related]

  • 19. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.
    Nalban N, Sangaraju R, Alavala S, Mir SM, Jerald MK, Sistla R.
    Cardiovasc Toxicol; 2020 Jun 01; 20(3):235-248. PubMed ID: 31485892
    [Abstract] [Full Text] [Related]

  • 20. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
    Essick EE, Ouchi N, Wilson RM, Ohashi K, Ghobrial J, Shibata R, Pimentel DR, Sam F.
    Am J Physiol Heart Circ Physiol; 2011 Sep 01; 301(3):H984-93. PubMed ID: 21666115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.